Flu season is about to finish in America, is about to start in Australia...
Anyone knows how Biota Pharmaceuticals perform this flu season, in term of revenue, royalties etc.....
What about it competitors ? Which one that we should look out for ?
Hopefully soon this March, our best CEO will give shareholders and the
Market a detailed plan for the success of the company.